Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jan Hrbek is active.

Publication


Featured researches published by Jan Hrbek.


Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia | 2012

Comparison of the results and complications of palmar and dorsal miniinvasive approaches in the surgery of scaphoid fractures. A prospective randomized study.

Pavel Drac; Igor Cizmar; Pavel Manak; Jan Hrbek; Michal Reška; Pavel Filkuka; Jana Zapletalova

AIMS To compare the functional results and complications associated with palmar percutaneous and dorsal limited approaches in the surgical treatment of nondisplaced or minimally displaced scaphoid fractures type B2. METHODS A total of 76 patients with acute nondisplaced or minimally displaced type B2 scaphoid fractures were included in a prospective randomised study. The assignment patients to groups according to type of operative approach was based on systematic sampling. Clinical follow-up, X-ray or CT imaging were performed at four, eight and twelve weeks and one year after the surgery. Patient satisfaction and the results of DASH form were evaluated as well. The differences were statistically tested. RESULTS We found significantly better flexion and grip strength in the group of palmar percutaneous aprroach during the follow-up examination at eight weeks after the surgery. Significantly better flexion of the same group persisted at twelve-week follow-up examination. No differences in results or complications were statistically significant up to one year follow up. CONCLUSIONS We found no advantage to the palmar percutaneous approach in the treatment of nondisplaced and minimally displaced scaphoid fractures type B2 compared to dorsal limited approach.


Journal of Bone Marrow Research | 2014

X-Ray in Multiple Myeloma - Not a ?Golden Standard? any More: Case Series

Jiri Minarik; Jan Hrbek; Tomas Pika; Martin Novák; Jaroslav Bacovsky; Miroslav Herman; Lumir Hrabalek; Ladislava Frysakova; Petra Pusciznova; Vlastimil Scudla

The assessment of myeloma bone disease (MBD) in multiple myeloma (MM) is recently based on conventional radiography (CR). Current International Myeloma Working Group (IMWG) guidelines mention other techniques such as whole-body MRI (WB-MRI) or positron emission tomography with computed tomography (PET-CT) but they still acknowledge CR as a “golden standard”. We designed a prospective study on imaging methods and myeloma bone disease (MBD) in patients with MM. The presented paper demonstrates two typical patients who did not qualify for further imaging based on IMWG guidelines. However, further examination using WB-MRI and low-dose CT (LD-CT) revealed severe involvement of the spine even with extramedullary masses of MM, and changed the therapeutic approach. We conclude that patients with monoclonal gammopathies should be examined with novel techniques and not rely on X-ray only as their diagnosis might be underestimated.


European Journal of Haematology | 2016

Prospective study of signalling pathways in myeloma bone disease with regard to activity of the disease, extent of skeletal involvement and correlation to bone turnover markers.

Jiri Minarik; Zuzana Hermanova; Pavla Petrova; Jan Hrbek; Jana Zapletalova; Petra Krhovska; Patrik Flodr; Tomas Pika; Jaroslav Bacovsky; Pavla Flodrova; Miroslav Herman; Vlastimil Scudla

The aim of our study was to address the utility of serum levels of selected parameters of myeloma bone disease (MBD) signalling with regard to the pathogenesis of multiple myeloma (MM), activity, markers of bone turnover and extent of skeletal changes.


Biomedical Papers-olomouc | 2016

Prospective comparison of conventional radiography, low-dose computed tomography and magnetic resonance imaging in monoclonal gammopathies

Jiri Minarik; Petra Krhovska; Jan Hrbek; Tomas Pika; Jaroslav Bacovsky; Miroslav Herman; Vlastimil Scudla

AIMS We carried out a prospective study in order to identify the best imaging approach for patients with newly diagnosed multiple myeloma (MM) and monoclonal gammopathy of undetermined significance (MGUS). METHODS We assessed the extent of myeloma bone disease (MBD) in 112 individuals - 84 patients with MM and 28 individuals with MGUS. For the detection of osteolytic involvement we used whole-body magnetic resonance imaging (WB-MRI), low-dose computed tomography (LD-CT) and conventional radiography (CR). Each method assessed the presence of osteolytic involvement, compressive fractures and extramedullary involvement in the following regions: skull, spine and chest, pelvis and humerus and femur. We compared the difference in the number and extent of osteolytic involvement, especially the findings in CR negative patients. RESULTS Conventional radiography showed no superiority in any of the evaluated regions, and failed in the detection of extramedullary massess and spine involvement. WB-MRI was best at imaging the spine including extramedullary involvement, however, detection of osteolytic lesions of the skull was limited in comparison with both CR and LD-CT. Both WB-MRI and LD-CT were comparable in imaging of lesions of pelvis, humerus, femur and the presence of extramedullary masses. LD-CT showed superiority in detection of skull lesions but lower sensitivity in spine compared to WB-MRI. CONCLUSIONS Our results confirm that relying solely on CR in the diagnostics of MM is insufficient. We suggest that the most suitable method for primary assessment of osteolytic involvement in monoclonal gammopathies should include either whole-body MRI together with CR of the skull or, with an equivalent sensitivity, whole body LD-CT.


Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia | 2009

UNUSUAL MANIFESTATION OF MULTIPLE MYELOMA: FOCAL AFFECTION OF CENTRAL NERVOUS SYSTEM IN A PATIENT WITH CHRONIC LYMPHOCYTIC LEUKAEMIA

Tomas Pika; Jaroslav Bacovsky; Miroslav Vaverka; Jan Hrbek; Jaromir Hubacek; Dagmar Spurna; Vlastimil Scudla


Blood | 2016

Prognostic Value of the Parameters of Myeloma Bone Disease Signaling in Patients with Newly Diagnosed Multiple Myeloma Treated with Proteasome Inhibitors

Jiri Minarik; Zuzana Hermanova; Jan Hrbek; Pavla Petrova; Patrik Flodr; Petra Krhovska; Tomas Pika; Jaroslav Bacovsky; Miroslav Herman; Vlastimil Scudla


Clinical Lymphoma, Myeloma & Leukemia | 2015

The relationship of myeloma bone disease signalling to the parameters of bone metabolism in monoclonal gammopathies

Jiri Minarik; Zuzana Hermanova; Pavla Petrova; Jana Zapletalova; Jan Hrbek; Petra Pusciznova; Jaroslav Bacovsky; Tomas Pika; Miroslav Herman; Vlastimil Scudla


Clinical Lymphoma, Myeloma & Leukemia | 2015

The relationship of the parameters of myeloma bone disease signalling pathways to the extent of bone involvement and extramedullary disease in monoclonal gammopathies

Jiri Minarik; Zuzana Hermanova; Pavla Petrova; Jana Zapletalova; Jan Hrbek; Petra Pusciznova; Jaroslav Bacovsky; Tomas Pika; Miroslav Herman; Vlastimil Scudla


Clinical Lymphoma, Myeloma & Leukemia | 2015

Correlation of the parameters of myeloma bone disease signalling to the activity of multiple myeloma and to the risk of transformation in monoclonal gammopathy of undetermined significance

Jiri Minarik; Zuzana Hermanova; Pavla Petrova; Jana Zapletalova; Jan Hrbek; Petra Pusciznova; Jaroslav Bacovsky; Tomas Pika; Miroslav Herman; Vlastimil Scudla


Blood | 2015

Assessment of the Parameters of Myeloma Bone Disease Signaling to the Extent of Skeletal Involvement, Bone Mineral Turnover and Activity of Multiple Myeloma

Jiri Minarik; Zuzana Hermanova; Pavla Petrova; Jana Zapletalova; Jan Hrbek; Petra Pusciznova; Jaroslav Bacovsky; Tomas Pika; Miroslav Herman; Vlastimil Scudla

Collaboration


Dive into the Jan Hrbek's collaboration.

Researchain Logo
Decentralizing Knowledge